Intersect ENT wins FDA nod for Sinuva polyp-disease-treating sinus implant
https://www.marketwatch.com/story/entellus-medical-to-be-acquired-by-stryker-for-24-a-share-in-cash-2017-12-07 Entellus Medical Inc. ENTL, +48.84% said Thursday it has reached a deal to be acquired by Stryker Corp. SYK, -0.75% for $24 a share in cash, in a deal with an equity value of about $662 million. Entellus is a leader in technology for ear, nose and throat ailments, including sinusitis, nasal airway obstruction and Eustachian tube dysfunction. The company’s […]
EndoGastric Solutions launches EsophyX Z+ GERD treatment device
FDA clears remote adjustments for Cochlear’s Nucleus implants
Advanced Bionics wins FDA nod for HiFocus Slimj cochlear implant electrode
Pavmed shares climb after Q3 EPS beat NOVEMBER 15, 2017 BY SARAH FAULKNER LEAVE A COMMENT Shares in Pavmed Inc. (NSDQ:PAVM) rose today after the medical device maker beat expectations on Wall Street with its third quarter results. The N.Y.-based company posted a net loss of -$5.37 million, or -40¢ per share, for the 3 months ended Sept. 30, for […]
Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation •November 13, 2017 Comment PLYMOUTH, Minn., Nov. 13, 2017 (GLOBE NEWSWIRE) — Entellus Medical, Inc. (ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced that Anthem, Inc. now covers balloon sinus dilation (BSD) for the treatment of chronic and recurrent […]